Shibin Zhou

19PUBLICATIONS
114CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

Jiaxin Ge, Joshua Urban, Sarah R DiNapoli

|May 27, 2025
NXPE1 alters the sialoglycome by acetylating sialic acids in the human colon.

Bum Seok Lee, Ashley Cook, Surojit Sur

|Jul 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

Brian J Mog, Nikita Marcou, Sarah R DiNapoli

|May 13, 2024
Cancer therapy with antibodies.

Suman Paul, Maximilian F Konig, Drew M Pardoll

|Mar 28, 2024
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.

Tushar D Nichakawade, Jiaxin Ge, Brian J Mog

|Aug 21, 2023
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.

Katharine M Wright, Sarah R DiNapoli, Michelle S Miller

Pageof 4

Frequent Collaborators

15 joint publications

Nickolas Papadopoulos

13 joint publications

Bert Vogelstein

12 joint publications

Brian J Mog

11 joint publications

Maximilian F Konig